CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The number of HIV patients with Kaposi's sarcoma, a once-rare cancer that became a marker for AIDS in the early days of the epidemic, has declined sharply due to the use of antiretroviral drugs, according to a European study released Monday. The annual incidence of the cancer fell 39% between 1994 and 2003, according to a study of nearly 10,000 HIV-positive people by the Royal Free and University College in London and several other European hospitals and health centers. Kaposi's sarcoma first appears as a brownish skin lesion, although it can also develop in the lungs, liver, and other internal organs. Until AIDS surfaced in 1981, the cancer was seen primarily in elderly Mediterranean men. It became one of the most common ailments plaguing AIDS patients in the 1980s. But the introduction a decade later of highly active antiretroviral therapy gave doctors a powerful new weapon against the opportunistic diseases that killed many AIDS victims. Anecdotal data and small studies had indicated that KS cases were declining as the new drugs suppressed levels of HIV in patients' blood and allowed their immune systems to recover. The large European study was, however, the first conclusive indication of a link between the therapy and declining cases of KS. The findings were published in the May 10 online edition of the American Cancer Society journal Cancer. In their study the Europeans noted that those with a higher current T-cell count or who had been on HAART therapy for a longer period of time had a decreased incidence of the cancer. "This indicates that the current CD4 count remains one of the most important prognostic factors for Kaposi's sarcoma, and patients who start HAART should experience a reduction in the risk of Kaposi's sarcoma if the CD4 count starts to rise," the researchers said. (Reuters)
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Lauren Boebert Caught Fondling Date’s Genitals During Family-Friendly Musical: Video
September 15 2023 11:20 PM
Don’t miss our latest news! Sign up today for our free newsletter.
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Texas Judge Strikes Down Anti-Drag Law Days After Another Upholds College Drag Ban
September 26 2023 10:13 PM
Oklahoma Black Trans Woman DéVonnie J’Rae Johnson Fatally Shot in Los Angeles
September 26 2023 5:57 PM
The Morning Show’s Reese Witherspoon and Julianna Margulies Have a Spark in New Clip
September 26 2023 5:53 PM
QAnon Believer Threatens to Kill U.S. Congresswoman He Thought Was Transgender
September 26 2023 2:00 PM
Gay Former N.J. Governor, Jim McGreevey, Considering Run for Jersey City Mayor
September 26 2023 10:40 AM